Enveric Biosciences Optimistic On Q4 And Full-Year Results: ‘Psychedelic-Inspired’ Meds For Future Growth
Nasdaq-listed psychedelics biotech Enveric Biosciences (NASDAQ:ENVB) shared its financial results for the fourth quarter of 2023 and the…